(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

MÉTODOS PARA TRATAR PACIENTES COM CÂNCER UROTELIAL LOCALMENTE AVANÇADO OU METASTÁTICO COM CONJUGADOS ANTICORPO-FÁRMACO (ADC) QUE SE LIGAM A PROTEÍNAS 191P4D12 EM COMBINAÇÃO COM PEMBROLIZUMABE

Em AnáliseInvention PatentPCT · US2023070812

Application data

Number

112025000032

Type

Invention Patent

Filing

07/24/2023

Publication

06/03/2025

PCT

US2023070812

Progress at the INPI

  1. Filing07/24/23
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 07/24/2023. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 06/03/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

AGENSYS, INC.

US

MERCK SHARP & DOHME LLC

US

SEAGEN INC.

US

See this company's full portfolio

Inventors

A. C. (pessoa física)

US

O. A. (pessoa física)

US

Technical data

Priority claims

US

63/392,067 · 07/25/2022

US

63/402,830 · 08/31/2022

US

63/504,183 · 05/24/2023

Abstract

MÉTODOS PARA TRATAR PACIENTES COM CÂNCER UROTELIAL LOCALMENTE AVANÇADO OU METASTÁTICO COM CONJUGADOS ANTICORPO-FÁRMACO (ADC) QUE SE LIGAM A PROTEÍNAS 191P4D12 EM COMBINAÇÃO COM PEMBROLIZUMABE. A presente invenção refere-se a métodos para tratar cânceres com conjugados anticorpo-fármaco (ADC) que se ligam à proteína 191P4D12 (Nectina-4) e pembrolizumabe.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

06/03/2025

RPI 2839

Alteração de dados cadastrais

#1.1

02/04/2025

RPI 2822

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.